Jonathan Kolatch’s Takeda Pharmaceutical TAK Stock Holding History

Jonathan Kolatch’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-177,815	Closed	-$2.55M	–	46
2022 Q1	$2.55M	Hold	177,815	–	–	0.23%	39
2021 Q4	$2.42M	Hold	177,815	–	–	0.2%	36
2021 Q3	$2.91M	Hold	177,815	–	–	0.22%	37
2021 Q2	$2.99M	Hold	177,815	–	–	0.2%	38
2021 Q1	$3.25M	Sell	177,815 -137,191	-44%	-$2.47M	0.16%	33
2020 Q4	$5.73M	Hold	315,006	–	–	0.35%	32
2020 Q3	$5.62M	Sell	315,006 -512,949	-62%	-$9.34M	0.43%	32
2020 Q2	$14.8M	Hold	827,955	–	–	1.58%	14
2020 Q1	$12.6M	Hold	827,955	–	–	2.3%	14
2019 Q4	$16.3M	Hold	827,955	–	–	2.24%	12
2019 Q3	$14.2M	Hold	827,955	–	–	1.55%	17
2019 Q2	$14.7M	Hold	827,955	–	–	1%	22
2019 Q1	$16.9M	Buy	+827,955	New	+$16.7M	1.15%	17

Other funds holding TAK

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jonathan Kolatch's TAK Position: Q2 2022 in Review

Jonathan Kolatch sold out of Takeda Pharmaceutical (TAK) in Q2 2022, closing a stake of 177,815 shares — an estimated $2.55M sold.

Jonathan Kolatch first reported a position in TAK in Q1 2019 and held it in 13 quarters. The position peaked at $16.9M in Q1 2019. 283 funds tracked by Wall St. Rank hold TAK as of Q2 2022.

Jonathan Kolatch reported no remaining Takeda Pharmaceutical position as of Q2 2022 after selling out during the quarter.
Jonathan Kolatch sold 177,815 Takeda Pharmaceutical shares in Q2 2022, an estimated $2.55M.
Jonathan Kolatch first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 13 quarters.
Jonathan Kolatch's Takeda Pharmaceutical position peaked at $16.9M in Q1 2019.
283 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2022.

Based on Redwood Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.